« Diabetes’ link to eating disorders | Home | Caution in reducing blood pressure in patients with diabetes, coronary disease »
Rapid-acting insulin analogues
Von diabetes-watch-blog.com | 12.Juli 2010
Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term therapy with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of maximum one year duration. This applies both in the comparison with human insulin and in the comparison between analogues only. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 November 2009……..
Topics: Diabetes, Diabetes Links, Englisch, News, Online | Kein Kommentar »
Kommentare
Man muss eingelogged sein um einen Kommentar zu posten.